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Abstract
Medulloblastomas are malignant brain tumors that
arise in the cerebella of children. The presumed cells-
of-origin are undifferentiated precursors of granule
neurons that occupy the external granule layer (EGL)
of the developing cerebellum. The overexpression of
proteins that normally stimulate proliferation of neural
progenitor cells may initiate medulloblastoma forma-
tion. Two known mitogens for neural progenitors are
the c-Myc oncoprotein and Sonic hedgehog (Shh), a
crucial determinant of embryonic pattern formation in
the central nervous system. We modeled the ability of
c-Myc and Shh to induce medulloblastoma in mice
using the RCAS/tv-a system, which allows postnatal
gene transfer and expression in a cell type–specific
manner. We targeted the expression of Shh and c-Myc
to nestin-expressing neural progenitor cells by inject-
ing replication-competent ALV splice acceptor (RCAS)
vectors into the cerebella of newborn mice. Following
injection with RCAS-Shh alone, 3/32 (9%) mice devel-
oped medulloblastomas and 5/32 showed multifocal
hyperproliferation of the EGL, possibly a precursor
stage of medulloblastoma. Following injection with
RCAS-Shh plus RCAS-Myc, 9/39 (23%) mice developed
medulloblastomas. We conclude that nestin-express-
ing neural progenitors, present in the cerebellum at
birth, can act as the cells-of-origin for medulloblasto-
ma, and that c-Myc cooperates with Shh to enhance
tumorigenicity.
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Introduction
Primitive neuroectodermal tumors (PNETs) are the most
common malignant brain tumors in children. Most often,
these tumors arise in the cerebellum where they are called
medulloblastomas. Although the precise histogenesis of
medulloblastoma remains uncertain, one hypothesis main-
tains that the cells-of-origin are undifferentiated precursors
of granule cell neurons (reviewed in Ref. [1]). Granule
neuron precursors (GNPs) occupy the external granule
layer (EGL), a germinal zone on the cortical surface of the
developing cerebellum. In mice, rapid proliferation of GNPs
after birth expands the EGL to amaximal thickness on postnatal
day 6. Afterwards, GNPs migrate inward where they differ-
entiate to generate the millions of neurons that make up the
internal granule layer of the cerebellum (reviewed in Ref. [2]).
Overexpression of proteins that normally stimulate prolifer-
ation and/or block differentiation of neural progenitor cells may
initiate medulloblastoma formation. One known mitogen for
neural progenitor cells is Sonic hedgehog (Shh), a secreted
protein that is a crucial determinant of embryonic pattern
formation in the central nervous system. Shh binds transmem-
brane protein, Patched (Ptc), at the cell surface. This interac-
tion activates a signal transduction pathway, leading to the
transcription of genes that govern various aspects of neural
development (reviewed in Ref. [3]). In the developing cerebel-
lum, Shh stimulates the proliferation of GNPs and blocks their
differentiation into neurons [4–6].
Mutations that activate the Ptc signaling pathway are onco-
genic. Transgenic mice expressing mutant Smoothened in the
skin develop basal cell carcinomas [7]. Inherited mutations in
the human PTC gene segregate in families with Gorlin’s Syn-
drome, a condition wherein affected individuals develop neural
tube defects, craniofacial abnormalities, and predisposition to
various neoplasms, including medulloblastomas [8]. PTC gene
mutations occur in 3% to 14% of sporadic medulloblastomas
[9–11]. Mice that are heterozygous defective for Ptc develop
medulloblastomas spontaneously [12,13]. Expression of the
wild-type Ptc allele in tumors from Ptc+/ mice suggests that
haploinsufficiency, not a two-hit mechanism of Ptc gene inacti-
vation, promotes medulloblastoma growth [14,15]. Intrauterine
injection of a Shh-expressing retrovirus into the cerebellum
of mice on embryonic day 13.5 induces medulloblastoma
formation [16].
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Anothermitogen for neural progenitors is the oncoprotein,
c-Myc. We have shown that c-Myc promotes the proliferation
of neural progenitor cells in mice [17]. The c-Myc gene is
amplified in 5% to 8% of human medulloblastomas and
overexpressed in 42% to 90% of cases [18,19]. Moreover,
the accumulation of c-MycmRNA is an unfavorable prognos-
tic indicator for medulloblastoma patients [20,21]. Although
these clinical correlations support a significant role for c-Myc
in medulloblastoma, we do not know whether c-Myc expres-
sion is an early event critical for tumor initiation, or a late event
involved in tumor progression.
We modeled the ability of c-Myc and Shh to induce
medulloblastoma in mice using the RCAS/tv-a system,
which allows postnatal gene transfer in a cell type–specific
manner [22,23]. This system utilizes replication-competent
ALV splice acceptor (RCAS) vectors, derived from the
avian retrovirus, ALV (subgroup A), and a transgenic
mouse line (Ntv-a) that produces TVA (the receptor for
ALV-A) under the control of the Nestin gene promoter.
Nestin is an intermediate filament protein expressed by
neuronal and glial progenitors [24]. After infection, RCAS
sequences integrate into the host cell genome where the
exogenous gene is expressed from a spliced message
under control of the constitutive retroviral promoter, LTR.
Combinations of genes can be transferred simultaneously
to individual cells by infecting them with multiple RCAS
vectors carrying different genes. We transferred genes
encoding Shh and c-Myc to nestin-expressing neural pro-
genitor cells in the cerebella of newborn mice. We show
here that nestin-expressing neural progenitors, present in
the cerebellum at birth, can act as the cells-of-origin for
medulloblastoma and that c-Myc cooperates with Shh to
enhance tumorigenicity.
Materials and Methods
Mice
The production of the Ntv-a transgenic mouse line has
been described previously [25]. Ntv-a/Ptc+/  mice were
created by breeding Ntv-a mice with mice containing a
mutant allele (Ptcneo67), wherein a neomycin resistance
cassette replaces exons 6 and 7 of the Ptc gene [13].
Therefore, the mice used in these experiments are mixtures
of the following strains: C57BL/6, BALB/C, FVB/N, and CD1.
Vector Constructs
RCAS-Shh was constructed by ligating full-length,
chicken Shh cDNA 3V of the retroviral env gene into parent
retroviral vector, RCASBP(A) [22]. The Shh insert contained
an in-frame, carboxy-terminal epitope tag containing six
repeats of the influenza virus hemagglutinin epitope (HA
tag). RCAS-Myc contained full-length, human c-Myc cDNA
as described previously [17].
Cell Culture
To produce live virus, we used DF-1 cells, an immortalized
line of chicken fibroblasts. DF-1 cells were cultivated in
DMEM supplemented with 5% fetal bovine serum, 5% calf
serum, 1% chicken serum, and 0.2% tryptose phosphate
broth. We transfected plasmid versions of RCAS vectors into
DF-1 cells and allowed them to replicate as viral vectors in
culture.
In Vivo Infection of Transgenic Mice
DF-1 virus producer cells were harvested by trypsin
digestion, collected by centrifugation, and resuspended in
phosphate-buffered saline. Injections of 1 to 2 Al (105 cells)
were made with a gas-tight Hamilton syringe into the lateral
cerebellum just posterior to the bregma of the skull, or into
the right frontal lobe just anterior to the coronal suture
within 48 hours after birth. The mice were sacrificed
12 weeks after injection, or sooner if they showed signs
of increased intracranial pressure or became debilitated.
The brains were removed and fixed in phosphate-buffered
formalin (10%). After fixation, each brain was divided into
quarters by parallel incisions in the coronal plane and
embedded in paraffin. Tissue sections (4 Am) were
mounted on glass slides for histochemical and immunocy-
tochemical analysis.
Immunocytochemistry
To analyze protein expression in tissue sections, we used
an immunoperoxidase staining method described previously
[26]. We used the following monoclonal antibodies (and
dilutions) from the indicated commercial sources: 9E10
(1:50)—human c-Myc (Santa Cruz Biotechnology; Santa
Cruz, CA); C19 (1:200)—mouse c-Myc (Santa Cruz Bio-
technology); F7 (1:50)—HA (Santa Cruz Biotechnology);
2F11 (1:100)—70-kDa neurofilament protein (Dako, Carpin-
teria, CA); TuJ1 (1:400)—hIII tubulin (Research Diagnos-
tics, Flanders, NJ); 401 (1:50)—nestin (Becton Dickinson
PharMingen, San Diego, CA); Mab377 (1:100)—NeuN
(Chemicon, Temecula, CA). To detect GFAP expression,
we used a rabbit, anticow polyclonal antibody (1:1000;
Dako). For double immunofluorescence staining, we incu-
bated formalin-fixed tissue sections with mouse monoclonal
antibody 9E10 (anti-Myc), and rabbit polyclonal antibody
Y11 (anti-HA; Santa Cruz Biotechnology), followed by sec-
ondary antibodies Cy5-conjugated antimouse IgG and FITC-
conjugated antirabbit IgG. Cell nuclei were counterstained
with propidium iodide. Digital images were generated using
confocal microscopy.
Western Blot Analysis of Primary Brain Cultures Infected
with RCAS-Shh
We prepared primary brain cultures from newborn Ntv-a
mice, infected them with RCAS-Shh viral vector, and pre-
pared whole cell lysates of the cultured cells 48 hours after
infection as described previously [17]. Protein samples
(60 Ag) were resolved by SDS-PAGE using 10% gels, trans-
ferred to nitrocellulose filters, and probed with monoclonal
antibody F7, directed against the HA epitope tag (85 amino
acids) located on the carboxy terminus of the recombinant
Shh protein. Detection was carried out using alkaline phos-
phatase–conjugated secondary antibody (goat antimouse
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IgG) and bromochloroindoyl phosphate/nitro blue tetrazo-
lium substrate.
Results
Overexpression of Shh in Neural Progenitors Induces EGL
Hyperproliferation and Medulloblastoma Formation
We modeled the ability of Shh and c-Myc, alone and in
combination, to induce medulloblastoma formation by inject-
ing RCAS vectors into the cerebella of newborn Ntv-a mice.
To study the effect of Ptc, we injected multiple, different
litters of mice born of Ntv-a/Ptc+/ parents. We reported
previously that RCAS-Myc produces an intact c-Myc protein
that stimulates proliferation of neural progenitor cells [17]. To
show that our RCAS-Shh vector was capable of producing
an intact Shh protein, we performed Western blot analysis of
primary brain cultures from Ntv-a mice before and after
infection with RCAS-Shh. Two major proteins, 60 and 37
kDa in size, were detected in infected cells with an antibody
directed against the carboxy-terminal HA epitope tag of
RCAS-Shh (Figure 1A). These two proteins correspond to
full-length Shh and a carboxy-terminal fragment resulting
from Shh autoproteolysis [27].
In 5/32 mice (16%) injected with RCAS-Shh alone, the
cerebella contained multiple foci where the EGL was
expanded to 10 to 20 cell layers (Figure 1B). Normally, the
EGL contains only none to two layers at the developmental
stages of mice we examined. The cells in the thickened
EGL expressed neuronal markers, hIII tubulin, and NeuN,
characteristic of proliferating GNPs. In 3/32 mice (9%),
RCAS-Shh produced infiltrating tumors that closely re-
sembled human medulloblastomas (Figure 1C ).
c-Myc Enhances Shh-Induced Medulloblastoma Formation
Immunoperoxidase staining with an antibody against
endogenous c-Myc showed abundant immunoreactivity in
the cytoplasm of cells within the EGL hyperproliferations and
the tumors (Figure 1D). c-Myc is normally a nuclear protein,
but it localizes to the cytoplasm in cerebellar Purkinje neu-
rons and in various tumors [28]. To determine whether the
cytoplasmic localization of c-Myc in mouse tumors accu-
rately modeled human medulloblastomas, we mapped the
subcellular localization of c-Myc in 16 human medulloblas-
toma specimens by immunocytochemistry. Consistent with
previous reports [19], c-Myc localized to the nucleus in 11
tumors. c-Myc immunoreactivity was restricted to the cyto-
plasm in four tumors and present in both compartments in
one tumor (Figure 1E ).
Immunoperoxidase staining of normal mouse cerebellum
at postnatal day 3 showed expression of c-Myc throughout
the EGL (not shown). Previous experiments indicate that
c-Myc helps maintain neural progenitor cells in an undiffer-
entiated and proliferating state [17]. Therefore, we hypothe-
sized that additional c-Myc might cooperate with Shh to
enhance tumorigenicity. To test this hypothesis, we injected
Ntv-a mice with RCAS-Shh plus RCAS-Myc. With this com-
bination, tumors developed in 9/39 mice (23%), a higher
percentage than with RCAS-Shh alone (Table 1). The
tumors arose from the lateral aspect of the cerebellar hemi-
sphere and infiltrated the adjacent brainstem (Figure 2A). In
one case, the tumor filled the fourth ventricle, a growth
pattern mimicking human medulloblastomas (Figure 2B ).
Like human medulloblastomas, these murine tumors were
composed of densely packed sheets of cells with hyper-
chromatic nuclei and scant cytoplasm, overlying a delicate
vascular network (Figure 2C ). Nuclear pleomorphism and
mitotic figures were present, indicating a rapid proliferative
rate. To verify that cells within the observed brain lesions
expressed the genes transferred through RCAS vectors, we
demonstrated specific staining of most cells within tumors
and EGL hyperproliferations with antibodies against epitope
tags within RCAS-Shh and RCAS-Myc (Figure 2, D and E ).
Double immunofluorescence staining showed that 5% to
10% of cells coexpressed Shh and c-Myc (Figure 2F ). All
tumors showed expression of synaptophysin, a reliable histo-
pathological marker for medulloblastomas [29] (Figure 3A).
We did not see tumors or EGL hyperproliferation in mice
injected with RCAS-Myc alone.
Some human medulloblastomas contain subpopulations
of cells expressing antigens characteristic of differentiated
neurons or glia, whereas others are composed entirely of
undifferentiated cells. To assess the differentiation status of
the mouse tumors, we performed an immunocytochemical
analysis of seven tumors induced by Myc +Shh and two by
Shh using antibodies specific for nestin, glial fibrillary acidic
protein (GFAP), neurofilament protein, NeuN, and hIII tubu-
lin. Nestin was detected in 4/9 tumors where the percentage
of nestin-expressing cells ranged from 5% to 20%. This low
percentage indicates the lack of selective pressure for
infected cells to maintain nestin expression in vivo. The cell
type specificity of the RCAS/tv-a system is limited to the
original gene transfer event, after which the transferred gene
is expressed from the retroviral promoter, LTR.
All tumors showed abundant expression of hIII tubulin in
the cytoplasm and NeuN in the nucleus (Figure 3, B and C ).
The expression of hIII tubulin by central nervous system
progenitor cells is an early marker of neuronal differentiation
[30]. NeuN is a nuclear protein expressed by many types of
mature neurons [31]. Like hIII tubulin, NeuN first appears at
developmental time points corresponding to the initiation of
neuronal differentiation. We did not detect the expression of
neurofilament protein, a marker of terminally differentiated
neurons, in any tumor. GFAP immunoreactivity was visible
only in processes of entrapped astrocytes interdigitated
among unstained tumor cells (Figure 3D). These immuno-
cytochemistry results support an origin of the induced tumors
from neuronal precursors.
Effect of Ptc Genotype and Gene Transfer Site on Tumor
Formation
Ptc+/ mice develop rhabdomyosarcomas and medullo-
blastomas spontaneously [12,13], but tumor incidence is
highly dependent upon genetic background. In point of fact,
rhabdomyosarcomas arise in 15% of CD1 Ptc+/ , mice but
no such tumors arise on a C57BL/6 background [32]. To
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determine whether medulloblastomas arise spontaneously
on the mixed genetic background of our Ntv-a/Ptc+/ mice,
we examined histological sections of brains from sixteen
1-year-old mice. We found no tumors in the forebrain,
brainstem, or cerebellum. Furthermore, we genotyped the
71mice injected into the cerebellum with RCAS-Shh alone or
in combination with RCAS-Myc. In this group, 53 were Ptc+/
and 18 were Ptc+/+. These proportions reflect the distribution
of alleles among the progeny of heterozygous parents
(Ptc nullizygotes die early in embryonic development).
Medulloblastomas occurred more frequently in Ptc+/+ mice
(5/18 = 28%) than in Ptc+/ mice (7/53 = 13%) (Table 2).
Similarly, EGL hyperproliferation occurred more frequently
in Ptc+/+ mice (4/18 = 22%) than in Ptc+/ mice (1/53 = 2%).
For these reasons, we cannot attribute the cerebellar lesions
observed following targeted expression of Shh and/or c-Myc
simply to spontaneous tumor formation.
PNETs arise in the cerebral hemispheres in children,
albeit much less frequently than in the cerebellum. Nestin-
expressing neural progenitors that are susceptible to
infection and gene transfer with RCAS vectors are present
in the cerebral hemispheres. To determine whether these
Figure 1. Histopathology of cerebellar lesions induced by Shh. (A)Western blot analysis of Ntv-amouse brain cultures infected with RCAS-Shh. Twomajor bands (60
and 37 kDa) corresponding to full-length Shh and carboxy-terminal peptide derived from autoproteolysis were detected with anti-HA antibody in infected cells (+) but
not uninfected cells ( ). (B) Focal hyperproliferation of EGL induced by Shh (Mo—molecular layer; Pu—Purkinje cell layer; IGL—internal granule layer). (C) Shh-
induced medulloblastoma infiltrating cerebellar cortex. (D) Cytoplasmic expression of endogenous c-Myc in tumor cells in Shh-induced medulloblastoma. (E) Human
medulloblastoma specimen showing expression of c-Myc in nuclei (arrow) and cytoplasm (arrowhead) of tumor cells. Scale bar = 110 lm (B,C), 55 lm (D), 27 lm (E).
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cells could produce PNETs when stimulated by Shh and c-
Myc, we injected RCAS-Shh plus RCAS-Myc into the right
frontal lobe of newborn Ntv-amice. Microscopic examination
of brain sections from 29 mice sacrificed after 13.7 weeks
showed that no brain tumors had formed.
Discussion
Using the RCAS/tv-a system, we have recapitulated in mice
some of the molecular events that mediate medulloblastoma
formation in humans. Expression profile analysis of human
medulloblastomas using oligonucleotide microarrays has
shown that transcriptional targets of Shh (Gli transcription
factors and Ptc) are frequently upregulated [33]. This profile
was found predominantly in a histological variant known as
desmoplastic medulloblastoma, which is characterized by
dense fibrous stroma surrounding aggregates of tumor cells.
The fact that our mouse tumors did not resemble desmo-
plastic medulloblastomas indicates that Shh/Ptc pathway
activation is not unique to the desmoplastic variant and
may be a more general molecular derangement in medullo-
blastoma.
Overexpression of the c-Myc oncogene occurs frequently
in human medulloblastomas and correlates with poor patient
prognosis [20,21]. We showed previously that c-Myc stimu-
lates the proliferation of undifferentiated neural progenitor
cells in the forebrain of mice, and we suggested that, through
this mechanism, c-Myc might promote PNET formation [17].
In the present study, c-Myc was not sufficient to induce
medulloblastoma formation. The enhanced tumorigenicity in
mice injected with two RCAS vectors expressing c-Myc and
Shh suggests that c-Myc cooperates with Shh to drive pro-
liferating neural progenitors into malignant transformation.
The fact that a minority of tumor cells coexpressed Shh and
c-Myc suggests that the tumorigenic effect of Shh (a secreted
protein) is mediated predominantly through a paracrine,
rather than an autocrine (cell-automatous), mechanism.
Table 1. Medulloblastoma Formation and EGL Hyperproliferation Induced by
Shh and/or c-Myc.
RCAS vector
Shh Myc +Shh Myc
Medulloblastoma 3/32 9/39 0/43
EGL hyperproliferation 5/32 0/39 0/43
Figure 2. Histopathology of medulloblastomas induced by c-Myc plus Shh. (A,B) Medulloblastomas infiltrating the lateral pons and cerebellum (Cb) and filling the
fourth ventricle (4V). (C) Cytoarchitecture of medulloblastoma induced by c-Myc plus Shh. Arrows indicate mitotic figures. (D,E) Immunoperoxidase staining of
virally transduced Shh and c-Myc in tumor cells with antibodies against HA (D) and Myc (E) epitopes. (F) Double immunofluorescence staining of Shh (green) and
c-Myc (red) shows colocalization (yellow) of both proteins in the cytoplasm of a subpopulation of medulloblastoma cells. Nuclei are counterstained with propidium
iodide (blue). Scale bar = 474 lm (A,B), 27 lm (C–E), 27 lm (F).
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Other mouse models of medulloblastoma have shown
that these tumors can arise by subversion of cell growth
pathways other than the Shh/Ptc pathway. Medulloblasto-
mas develop in p53-null mice after conditional inactivation of
the Rb gene [34], or in combination with homozygous loss of
Lig4, which encodes a nuclear ligase critical for DNA repair
[35]. Loss of p53 accelerates medulloblastoma formation in
Ptc+/ mice [36]. Transgenic mice expressing SV40 virus
large T antigen, which functionally inactivates both Rb and
p53, develop brainstem PNETs [37]. Considering the fact
that loss-of-function mutations in either RB or P53 rarely
occur in human medulloblastomas, our model has the
advantage of more closely paralleling the molecular path-
ways relevant to human tumors.
Other investigators recently reported that ectopic expres-
sion of Shh in prenatal mouse cerebellum induces EGL
thickening and medulloblastomas [16]. They utilized a
murine leukemia virus vector, injected in utero, to infect a
broad population of dividing cells. Our results confirm their
observations and extend them by showing that c-Myc coop-
erates with Shh to enhance tumorigenicity. Furthermore, our
results in Ntv-a mice define a more narrow population of
candidate cells-of-origin for medulloblastomas, namely,
nestin-expressing neural progenitors.
We cannot conclude that the tumors originated from
GNPs within the EGL because we did not specifically target
these precursor cells. Nevertheless, several features of our
model are consistent with a GNP origin for medulloblastoma.
First, the EGL contains the highest concentration of mitoti-
cally active, nestin-expressing cells susceptible to infection
with RCAS vectors. Second, significant numbers of cells
within the EGL thickenings and in the tumors expressed
hIII tubulin and NeuN—markers for early neuronal differ-
entiation. Finally, the coexistence of EGL thickening and
medulloblastoma in cerebella injected with RCAS-Shh
implicates hyperproliferation of GNPs as a precursor stage
in the genesis of medulloblastoma.
We could not produce tumors in the forebrain by inject-
ing RCAS-Shh, alone or in combination with RCAS-Myc,
even though nestin-expressing progenitors are present in
that part of the brain in postnatal mice. These cells are
known to give rise to glioblastomas in vivo with specific
activation of the Ras and Akt signaling pathways [38], and
Figure 3. Expression of neural antigens in medulloblastomas induced by c-Myc plus Shh. Expression of synaptophysin (A), bIII tubulin (B), and NeuN (C) in tumor
cells and GFAP (D) in processes of entrapped astrocytes. Scale bar = 27 lm.
Table 2. Effect of Ptc Genotype on Medulloblastoma Formation and EGL
Hyperproliferation Induced by Shh and c-Myc +Shh.
Ptc genotype
Ptc+/+ Ptc+/
Medulloblastoma 5/18 7/53
EGL hyperproliferation 4/18 1/53
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to oligodendrogliomas with overexpression of platelet-
derived growth factor [39]. Our observation that cerebral
progenitor cells are less responsive to the same molecules
that are potent mitogens for cerebellar progenitors could
explain why cerebral hemisphere PNETs are rare com-
pared with cerebellar medulloblastomas.
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